CASI Pharmaceuticals Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CASI Pharmaceuticals (CASI) Reports Q1 Loss of $0.06/Share
May 15, 2015 7:03 AM EDTCASI Pharmaceuticals (NASDAQ: CASI) reported Q1 EPS of ($0.06), versus ($0.05) reported last year. Revenue for the quarter came in at $23.7 thousand, versus $0 reported last year.
For earnings history and earnings-related data on CASI Pharmaceuticals (CASI) click here.
... More